MONECO Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$497K Sell
3,568
-124
-3% -$17.4K 0.04% 307
2025
Q4
$453K Sell
3,692
-75
-2% -$9.12K 0.04% 321
2025
Q3
$418K Sell
3,767
-1,086
-22% -$123K 0.03% 332
2025
Q2
$538K Sell
4,853
-492
-9% -$52.4K 0.05% 281
2025
Q1
$599K Sell
5,345
-657
-11% -$67.8K 0.06% 244
2024
Q4
$554K Sell
6,002
-351
-6% -$31.6K 0.06% 258
2024
Q3
$533K Buy
6,353
+87
+1% +$6.64K 0.07% 248
2024
Q2
$430K Buy
6,266
+125
+2% +$8.34K 0.06% 258
2024
Q1
$450K Sell
6,141
-176
-3% -$13.5K 0.07% 250
2023
Q4
$512K Buy
6,317
+691
+12% +$53.8K 0.1% 212
2023
Q3
$422K Buy
5,626
+558
+11% +$42.9K 0.11% 204
2023
Q2
$391K Buy
5,068
+232
+5% +$18.5K 0.11% 209
2023
Q1
$401K Buy
4,836
+833
+21% +$69K 0.12% 197
2022
Q4
$344K Buy
4,003
+252
+7% +$20K 0.12% 180
2022
Q3
$231K Buy
+3,751
New +$237K 0.09% 211
2021
Q4
Sell
-2,974
Closed -$208K 255
2021
Q3
$208K Sell
2,974
-377
-11% -$26.5K 0.08% 236
2021
Q2
$231K Buy
+3,351
New +$224K 0.11% 195
2020
Q3
Sell
-2,632
Closed -$203K 162
2020
Q2
$203K Buy
+2,632
New +$202K 0.16% 129

Other funds holding GILD

MONECO Advisors's GILD Position: Q1 2026 in Review

MONECO Advisors reduced its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, selling an estimated $17.4K and leaving 3,568 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #307.

MONECO Advisors first reported a position in GILD in Q2 2020 and has held it in 18 quarters since. The position peaked at $599K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • MONECO Advisors held 3,568 shares of Gilead Sciences worth $497K as of Q1 2026.
  • MONECO Advisors sold 124 Gilead Sciences shares in Q1 2026, an estimated $17.4K.
  • Gilead Sciences made up 0.04% of MONECO Advisors's portfolio in Q1 2026, its #307 holding.
  • MONECO Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 18 quarters since.
  • MONECO Advisors's Gilead Sciences position peaked at $599K in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.